• DE
  •   |  
  • FR
  •   |  
  • IT

    • NEWS

    29.04.2012

    Lancierung der Sonderbriefmarke "Blutspende"

    Festakt auf dem Bundesplatz Bern zur Lancierung der Sonderbriefmarke "Blutspende" am 8.Mai 2012 - dem Weltrotkreuztag - ab 15 Uhr[leggi]

    13.02.2012

    Avvertimento

    Avvertimento riguardo „Association Suisse des Donneurs de Sang Bénévoles“[leggi]

    Risultati da 1 a 2 su 7
    << Prima < Precedente 1-2 3-4 5-6 7-7 Prossima > Ultima >>

    Pubblicazioni scientifiche

    Donazione di sangue e aferesi

     

    Donatori

    Pubblicazioni del Servizio regionale trasfusionale Basel

    • Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH. Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors. J Infect Dis. 2009 Mar 15;199(6):837-46.
    • Claudia Pittori, Andreas Buser, Urs E. Gasser, Jörg Sigle, Shabahang Job, Morven Rüesch, André Tichelli, Laura Infanti . A pilot Iron Substitution Program in female blood donors with iron deficiency without anemia. Vox Sanguinis accepted for publication 2010

    Pubblicazioni del Servizio regionale trasfusionale Zürich

    • Lorenz Götte, Alois Stutzer, Beat M. Frey. Prosocial Motivation and Blood Donations: A Survey of the Empirical Literature. Transfusion Medicine and Hemotherapy, Volume 37, Issue 3, June 2010
    • Lorenz Goette, Alis Stutzer, Gürcan Yavuzcan, and Beat M. Frey. Free cholesterol testing as a motivation device in blood donations: evidence from field experiments. Transfusion. 2008;Nov 25 [Epub ahead of print]
    • Beat M. Frey, Axel Rüfer, Karin Hardegger, Gabriela Bachmann, Christine Kuhn, Irène Schmid, Franziska Wägli and Oswin Ochmann. Iron balance remains stable in life-long blood donors. Forum Med. Suisse. 2007;7 (Suppl. 35), 78 S
    • A. Rüfer, P. Jacquet, WA. Wuillemin and B.M. Frey. The end of a diagnostic odyssey – a case of Chuvash polycythemia. Forum Med. Suisse. 2007;7 (Suppl. 35), 72 S
    • Oswin Ochmann, Karin Hardegger and Beat M. Frey. Iron balance in young blood donors: Is the latent iron deficiency syndrome (LIDS) universal? Forum Med. Suisse. 2007;7 (Suppl. 35), 73 S
    • Oswin Ochmann, Alois Stutzer, Gertrud Staeheli and Beat M. Frey. Blood donor recruitment: Efficacy of various invitation approaches on donor’s descision making. 40. Jahreskongress DGTI. 2007

    Aferesi

    Pubblicazioni del Servizio regionale trasfusionale Bern

    • Fontana S, Groebli R, Mansouri Taleghani B. Progenitor cell recruitment during individualized high-flow, large volume apheresis for autologous transplantation improves collection efficiency. Transfusion. 2006;46:1408-1416
    • Lersch F, Fontana S, Nohl F, Mansouri Taleghani B. Pica, peanuts and plasma exchange. Transfusion. 2006;46:1853-1854
    • Fontana S, Mordasini L, Keller P, Mansouri Taleghani B. Prospective, paired crossover comparison of multiple platelet aphereses with two different single-needle cell separators. Transfusion. 2006;46:2004-2010
    • Fontana S, Mordasini L, Keller P, Mansouri Taleghani B. Platelet recruitment during multiple platelet apheresis differs between cell separators. Transfusion. submitted

    Pubblicazioni del Servizio regionale trasfusionale Zürich

    • L. Goette, A. Stutzer, G. Yavuzcan and B.M. Frey. Free cholesterol testing as a motivation device in blood donations: Evidence from field experiments. Transfusion. March 2009;Vol. 49, 524-531
    • G. Schorer, G. Brittenham, R. Darnuzer, M. Westerman, Beat M. Frey. Sequential blood donation decreases total body iron stores and serum hepcidin. 77. Jahresversammlung der SGIM/SGH, Basel. 2009
    • G. Schorer, G. Brittenham, R. Darnuzer, M. Westerman, Beat M. Frey. Iron balance in repeat bood donors – the role of Hepcidin. 42. Jahreskongress der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI), Rostock. 2009
    • Adriana Méndez, Franziska Wägli, Irène Schmid and Beat M. Frey. Frequent platelet apheresis donation in volunteer donors with haemoglobin <125g/l are safe and efficient. Transfusion and Apheresis Science. 2007;36:47-53
    • A. Méndez, B.M. Frey. Chronic Platelet Apheresis Donation of Volunteer Donors with Hb<125 g/l is save and efficient. Swiss Medical Forum. Suppl 12, 2003;Mai 7, 70s, abstr. 432
    • Dagmar Matz, Fränzi Wägli, Ulrike Murer, Monika Furrer and Beat M. Frey. Collection of single donor platelet concentrates by TRIMA ACCEL, COBE/SPECTRA and AMICUS CRESCENDO devices: A large, prospective-randomized, comparative-crossover study. Transfusion Medicine and Hemotherapy. Vol 32, Suppl 1, 2005; abstr P1.23, S.41
    • A. Mendez, B.M. Frey. Die Thrombozytenspende von Blutspendern mit Hämoglobin < 125 g/l ist sicher und effizient. Inauguraldissertation an der Medizinischen Fakultät Zürich. 2004

    Immuno-ematologia

     

    Pubblicazioni del Servizio regionale trasfusionale Bern

    • Hult AK, Yazer MH, Jorgensen R, Hellberg A, Hustinx H, Peyrard T, Palcic MM and Olsson ML. Weak A phenotypes associated with novel ABO alleles carrying the A2-related 1061C deletion and various missense substituions. Transfusion. 2010 50:1471-86.
    • Niederhauser C, Hustinx H. Von der Erbsubstanz über die molekulare Blutgruppendiagnostik zum Routinescreening des Rhesus-D-Gens bei Blutspendern. pipette (Sonderheft Transfusionsmedizin). 2009;4:13-16
    • Fontana S. Die "Blutgruppen" der Thrombozyten und Leukozyten: Bedeutung in der Transfusionsmedizin und Immunhämatologie. pipette (Sonderheft Transfusionsmedizin). 2009;4:21-23
    • Hustinx H, Poole J, Bugert P, Gowland P, Still F, Fontana S, Scharberg E.A, Tilley L, Daniels G, Niederhauser C. Molecular basis of the Rh antigen RH48 (JAL). Vox Sanguinis. 2009;96:234-239
    • Hustinx H, Fontana S, Gowland P, Niederhauser C. Will Genotyping Replace Serology in Future Routine Blood Grouping? – Opinion 2. Transfus Med Hemother. 2009;96:234-239
    • Körmöczi G.F, Dauber E.-M, Swoboda S, Mansouri Taleghani B, Fontana S, Hustinx H, Sikyr S, Colucci G, Schwarzinger I, Fritsch G, Mayr W.R. Spontaneous Rh Phenotype Splitting: Loss of Heterozygosity on Chromosome 1 in Different Blood and Bone Marrow Cell Subsets. Transfusion Medicine and Hemotherapy. 2009;36 (S1):P1.06
    • Hustinx H, Scholl N, Gowland P, Krieg R, Stolz M, Fontana S, Niederhauser C. Screening of Swiss blood donors for an IgA deficiency and its significance for the investigation of anaphylactic transfusion reactions. SMF Swiss Medical Forum. 2009;9(Suppl. 46):P174
    • Hustinx H, Niederhauser C, Gowland P, Still F, Lovey P, Fontana S. Requirements to the blood transfusion service in the case of a patient with multiple antibodies including a rare anti-Doa. SMF Swiss Medical Forum. 2009;9(Suppl. 46):P197
    • Reesink HW, Engelfriet CP, Schennach H, Gassner C, Wendel S, Fontão-Wendel R, de Brito MA, Sistonen P, Matilainen J, Peyrard T, Pham BN, Rouger P, Le Pennec PY, Flegel WA, von Zabern I, Lin CK, Tsoi WC, Hoffer I, Barotine-Toth K, Joshi SR, Vasantha K, Yahalom V, Asher O, Levene C, Villa MA, Revelli N, Greppi N, Marconi M, Tani Y, Folman CC, de Haas M, Koopman MW, Beckers E, Gounder DS, Flanagan P, Wall L, Aranburu Urtasun E, Hustinx H, Niederhauser C, Massey E, Gray A, Needs M, Daniels G, Callaghan T, Flickinger C, Nance SJ, Meny M. International Forum: Donors with a rare pheno (geno) type. Vox Sanguinis. 2008;95:236-253
    • Hustinx H, Poole J, Bugert P, Gowland P, Still F, Fontana S, Scharberg EA, Tilley L, Daniels G, Niederhauser C. The JAL(RH48) Antigen in Black and Caucasian Individuals: A Serological and Molecular Study. Transfusion Medicine. 2008;18: Suppl. 2: 21
    • Niederhauser C, Hustinx H, Gowland P, Still F, Mansouri Taleghani B, Fontana S, Thierbach J, Tissot JD, Maier A. Molecular RHD Screening of Serological Rh D Negative Swiss Blood Donors. Transfusion Medicine and Hemotherapy. 2008;35(suppl 1):16
    • Schütz A, Kurta V, Hustinx H, Mansouri Taleghani B, Niederhauser C, Fontana S. Comparison of Iso-Haemolysin and –Agglutinin Testing of Platelet Donors in the Context of the Prevention of Haemolytic Transfusion Reactions. Transfusion Medicine and Hemotherapy. 2008;35(suppl 1):70
    • Seltsam A, Strigens S, Levene C, Yahalom V, Moulds M, Moulds JJ, Hustinx H, Weisbach V, Figueroa D, Bade-Doeding C, Deluca DS, Blasczyk R. The molecular diversity of Sema7A, the semaphorin that carries the JMH blood group antigens. Transfusion. 2007;36:228-229
    • Chen Q, Hustinx H and Felgel WA. The RHCE allele ceSL: the second example for D antigen expression without D-specific amino acids. Transfusion. 2006;46:766-772
    • Poole J, Warke N, Hustinx H, Mansouri Taleghani BM, Martin P, Finning K, Crew VK, Green C, Bromilow I, Daniels G. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen. Transfusion. 2006;46:1879-85
    • Storry JR, Johannesson JS, Poole J, Strindberg J, Rodrigues MJ, Yahalom V, Levene C, Fujita C, Castilho L, Hustinx H, and Olsson ML. Identification of six new alleles at the FUT1 and FUT2 loci in ethnically diverse individuals with Bombay and Para-Bombay phenotypes. Transfusion. 2006;46:2149-2161
    • Flegel WA, Eicher NI, Doescher A, Hustinx H, Gowland P, Mansouri Taleghani B, Petershofen EK, Bauerfeind U, Ernst M, von Zabern I, Schrezenmeier H and Wagner FF. In-frame triplet deletions in RHD alter the D antigen phenotype. Transfusion. 2006;46:2156-2161
    • Hosseini-Maaf B, Irshaid NM, Hellberg A, Wagner T, Levene C, Hustinx H, Steffensen R, Chester MA, Olsson ML. New and unusual O alleles at the ABO locus are implicated in unexpected blood group phenotypes. Transfusion. 2005;45:70-81
    • Gassner C, Doescher A, Drnovsek TD, Rozman P, Eicher NI, Legler TJ, Lukin S, Garritsen H, Kleinrath T, Egger B, Ehling R, Kormoczi GF, Kilga-Nogler S, Schoenitzer D, Petershofen EK. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion. 2005;45:466-468
    • Mansouri Taleghani B, Meyer O, Fontana S, Ahrens N, Novak U, Borner MM, Salama A. Oxaliplatin-induced immune pancytopenia. Transfusion. 2005;45:704-8
    • Nydegger UE, Fontana S. Physiologie von Immunkomplexen. Teil 1. Swiss Medical Forum. 2005;5:335-340
    • Fontana S, Gadola S, Mansouri Taleghani B, Nydegger UE. Klinische Bedeutung von Immunkomplexen. Teil 2. Swiss Medical Forum. 2005;5:355-361
    • Matthes T, E Tullen, J Poole, J Banks, M Nagy, MJ Stelling, F Boehlen, M Michel, P Beris, H Hustinx, V Crew and G Daniels. Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti-IFC. Transfusion. 2002;42:1448-1457
    • Irshaid NM, NI Eicher, H Hustinx, J Poole and ML Olsson. Novel alleles at the JK blood group locus explain the absence of the erythrocyte urea transporter in European families. Br J Haematol. 2002;116:445-453
    • Wagner FF, NI Eicher , JR Jorgensen, CB Lonicer and WA Flegel. DNB: a partial D with anti-D frequent in Central Europe. Blood. 2002;100:2253-2256
    • Wagner FF, B Ladewig, KS Angert, GA Heymann, NI Eicher and WA Flegel. The DAU allele cluster of the RHD gene. Blood. 2002;100:306-311
    • Müller, TH, FF Wagner, A Trockenbacher, NI Eicher, WA Flegel, D Schönitzer, F Schunter and C Gassner. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion. 2001;41:45-52
    • Salama, A, P Schwind, K Schönhage, R Genth, C Cotting, H Hustinx, R Krieg, U Nydegger and I Aebischer. Rapid detection of antibodies to immunoglobulin A molecules by using the particle gel immunoassay. Vox Sanguinis. 2001;81:45-48
    • Wagner FF, A Frohmajer, B Ladewig, NI Eicher, CB Lonicer, TH. Müller, MH Siegel, and WA Flegel. Weak D alleles express distinct phenotypes. Blood. 2000;95:2699-2708

    Abstracts del Servizio regionale trasfusionale Bern

    • Lejon S, Gowland P, Fontana S, Niederhauser C and Hustinx H. Transfusion and Apheresis Science. DARA, a new DAR variant – serologic and molecular differences between DARA, weak D type 4.2.2, DV type 7, DARE and DAR. 2010; 43 (suppl. 1) S13: 23.
    • Thuresson B, Hosseini-Maaf B, Hult AK, Hustinx H, Chester MA and Olsson ML. A novel Bweak hybrid allele with a non-repeating CBF-enhancer region. Vox Sanguinis. 2010; 99 (suppl. 1): P-0735: 362.
    • Sigle JP, Hustinx H, Storry JR Olsson ML and Buser A. Mixed field agglutination in AB0 typing after allogeniec HSCT: influence of recipient secretor status. Vox Sanguinis. 2010; 99 (suppl. 1): P-0742: 365.
    • Hult AK, Yazer MH, Jorgensen R, Hellberg A, Palcic MM, Olsson ML, Peyrard T and Hustinx H. Weak A phenotypes associated with novel AB0 alleles carrying the A2 –related 1061C deletion and various missense amino acid substitutions. Vox Sanguinis. 99 (suppl. 1): P-0776: 377.
    • Venturelli D, Lunghi M, Baldini M, Hustinx H, Neri I, Mazza V and Montagnani G. Modulation of antibodies to Cromer Blood Group System antigens (anti Tcc(a)) and anti-Kidd (JKa) antibodies during late pregnancy. Transfusion. 2010; 50 (Suppl. S2): SP264: 156A.
    • Sigle JP, Boldanova T, Flückiger U, Infanti L, Rüfli T, Hustinx H and Buser A. Transfusion reaction due to coldagglutinins in a patient with Malaria. Swiss Medical Forum. 2010; 10 (Suppl. 50): P225:95 S.
    • Lejon S, Gowland P, Fontanan S, Niederhauser C and Hustinx H. A new DAR variant, DARA – serologic and molecular differences between DARA, Weak D type 4.2.2, Dv type 7, Dare and Dar. Transfusion Medicine. 2010; 20 (Suppl 1): S122: 12.
    • Green C, Bugert P, Hustinx H, Daniels G and Karamatic V. Crew. A silent mutation 939g> A in RHCE (Pro313) causes loss of a splice site and complete skipping of exon 6 resulting in expression of a novel E antigen. Transfusion Medicine. 2010; 20 (Suppl 1): PO20: 33.

    Pubblicazioni del Servizio regionale trasfusionale Vaud

    • Conne J, Schneider P, Tissot JD. Role of enzyme-treated cells in red blood cell antibody screening using the gel test: a study of anti-RH1, -RH2, and ?RH3 antibodies. J Clin Lab Anal. 2007;21:61-66

    Pubblicazioni del Servizio regionale trasfusionale Zürich

    • Antje Enekwe, Jutta Thierbach, Barbara Ziegler, Beat M. Frey. Erhöhte Inzidenz maligner hämatologischer Erkrankungen bei Blutspendern mit positivem direkten Antiglobulintest (DAT) Swiss Medical Forum, Supplementum 50, 2010;18(18)
    • C. Engström, B. Grossrieder, C. Gassner, B.M. Frey. Serology helps moleculardiagnostics to solve a rare case of Homozygous FY*X/FY*X - Consequences for Transfusion Recommendations. Transfusion and Apheresis Science, Vol. 43, Suppl. 1, S12, September 2010
    • A. Siderow, J. Ries, B. Grossrieder, J. Reichenbach, R. Seger, M. Hergersberger, B. Röthlisberger, B.M. Frey. Association of X-linked chronic granulomatous disease with the rare McLeod phenotype – a case report. 42. Jahreskongress der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI), Rostock. 2009
    • A. Siderow, J. Ries, B. Grossrieder, J. Reichenbach, R. Seger, M. Hergersberg, B.M. Frey. McLeod phenotype associated with X-linked chronic granulomatours disease: A liason with serious consequences. 77. Jahresversammlung der SGIM/SGH, Basel. 2009
    • M. Hergersberg, C. Ottiger, B.M. Frey, H.H. Jung, J. Reichenbach, R. Seger, B. Udd, J. Bruni, A.R. Huber, B. Röthlisberger. Characterization of X-chromosomal deletion in two patients with McLeod Syndrome by Array Comparative Genomic Hybridization. Swiss MedLab, Int. Congress, Montreux. September 16-19, 2008
    • M. Hergersberg, B. Röthlisberger, C. Ottiger, B.M. Frey, H.H. Jung, B. Udd, A.R. Huber. Characterization of a 1.7 Mb X-chromosomal deletion in a patient with McLeod Syndrome by Array CGH. 19. Jahreskongress der Deutschen Gesellschaft für Humangenetik. 2008
    • T. Dorn, B. Bader, A. Danek, H.H. Jung, Y. Achermann, B.M. Frey and G. Krämer. Seizures of extratemporal origin as a prominent feature in a Tamilian male with Chorea-Acanthocytosis. 27th Int. Epilepsy Congress Proceedings. Epilepsia. 2007;48 (Suppl. 7) p 473
    • Beat M. Frey, Monika Furrer, Pascale Jaquet. Molecular Genotyping of antithetical KEL polymorphisms by exontargeting PCR-RFLP. 40. Jahreskongress DGTI. 2007
    • Marcelo Miranda, Claudia Castiglioni, Martin Hergersberg, Adrian Danek, Hans H. Jung and Beat M. Frey. Phenotypic Variability of a Distinct Deletion in McLeod Syndrome. Mov Disord. 2007;Vol.22, No.9:1358-1361
    • Hans H. Jung, Adrian Danek and Beat M. Frey. MCLEOD SYNDROME - A NEURO-HEMATOLOGICAL DISORDER Vox Sanguinis. 2007;93:112-121
    • C.P. Engelfried, H.W. Reesink, G.F. Körmöczi, W.R. Mayr, S. Panzer, D. Schönitzer, R. Fontao-Wendel, S. Wendel, A. Long, M.H. Dziegiel, V. Kretschmer, R. Karger, F. Morelati, N. Revelli, M.A. Villa, M. Lai, M. de Haas, E. van der Schoot, M. Overbeeke, P. Maaskant, D. Gounder, P. Flanagan, G.B. Solheim, B. Zupanska, B. Michalewska, E. Muniz-Diaz, C. Martin-Vega, B.M. Frey, A. Mendez, S.A. Kochman, J.S. Epstein, G. Garratty, C. Lomas-Francis, C.M. Westhoff. Testing for weak D – International Forum. Vox Sanguinis. 2006;90:140-153
    • Christian Rüegg, Adriana Méndez, Edi Matheis, Annelies Böhlen-Bodmer and Beat M. Frey. Assignement of Lub-Negativity for rare donor selection requires sophisticated techniques based on molecular genotyping. Transfusion Medicine and Hemotherapy. Vol 32, Suppl 1, 2005;abstr P4.14, S.55
    • Adriana Méndez, Pascale Jaquet, Monika Furrer and Beat M. Frey. Quantification of D-Antigen density of weakD red blood cell phenotypes by flowcytometry. A rapid method to estimate the anti-D immunization risk. Swiss Medical Forum. Suppl. 23, 2005;May 11th, 22s, abstr S71
    • Adriana Méndez, Pascale Jaquet, Karin Hardegger, Annette Schille, Monika Furrer and Beat M. Frey. Prevalence and genotype of weakD red blood cell phenotypes in Swiss blood donors. Swiss Medical Forum. Suppl. 23, 2005;May 11th, 70s, P204 (abstr)
    • Edi Matheis, Annelies Böhlen-Bodmer, Karin Hardegger, Annette Schille and Beat M. Frey. Prevalence and specificity of blood group antibodies in Swiss blood donors. Transfusion Medicine and Hemotherapy. Vol 32, Suppl 1, 2005;abstr P4.12, S.54
    • H.H. Jung, M. Hergersberg, M. Vogt, J. Pahnke, V. Treyer, S.S. Kollias, D. Russo, B.M. Frey. McLeod Phenotype associated with a XK Missense Mutation without Hematological, Neuromuscular or Cerebral Involvement. Transfusion. 2003;Vol 43: 928-38
    • V. Ankelmann, B.M. Frey, M. Vogt, R. Eggmann, C. Janda, I. Galimberti, H.U. Lutz. Coombs-positive Red Blood Cells of Healthy Blood Donors carry Anti-C3/C3b Naturally Occurring Antibodies (Nabs). Swiss Medical Forum. Suppl 8, April 10, 2002;abstr 342.
    • B.M. Frey, M. Furrer, M. Vogt, M. Hergersberg, V. Treyer, S. Kollias, H.H. Jung. The G1016A XK Missense Mutation causes McLeod Immunophenotype without systemic Involvement. Vox Sanguinis. 2002;83, Suppl 2, P-072 (abstr)

    Immuno-ematologia

     

    Pubblicazioni del Servizio regionale trasfusionale Bern

    • Hult AK, Yazer MH, Jorgensen R, Hellberg A, Hustinx H, Peyrard T, Palcic MM and Olsson ML. Weak A phenotypes associated with novel ABO alleles carrying the A2-related 1061C deletion and various missense substituions. Transfusion. 2010 50:1471-86.
    • Niederhauser C, Hustinx H. Von der Erbsubstanz über die molekulare Blutgruppendiagnostik zum Routinescreening des Rhesus-D-Gens bei Blutspendern. pipette (Sonderheft Transfusionsmedizin). 2009;4:13-16
    • Fontana S. Die "Blutgruppen" der Thrombozyten und Leukozyten: Bedeutung in der Transfusionsmedizin und Immunhämatologie. pipette (Sonderheft Transfusionsmedizin). 2009;4:21-23
    • Hustinx H, Poole J, Bugert P, Gowland P, Still F, Fontana S, Scharberg E.A, Tilley L, Daniels G, Niederhauser C. Molecular basis of the Rh antigen RH48 (JAL). Vox Sanguinis. 2009;96:234-239
    • Hustinx H, Fontana S, Gowland P, Niederhauser C. Will Genotyping Replace Serology in Future Routine Blood Grouping? – Opinion 2. Transfus Med Hemother. 2009;96:234-239
    • Körmöczi G.F, Dauber E.-M, Swoboda S, Mansouri Taleghani B, Fontana S, Hustinx H, Sikyr S, Colucci G, Schwarzinger I, Fritsch G, Mayr W.R. Spontaneous Rh Phenotype Splitting: Loss of Heterozygosity on Chromosome 1 in Different Blood and Bone Marrow Cell Subsets. Transfusion Medicine and Hemotherapy. 2009;36 (S1):P1.06
    • Hustinx H, Scholl N, Gowland P, Krieg R, Stolz M, Fontana S, Niederhauser C. Screening of Swiss blood donors for an IgA deficiency and its significance for the investigation of anaphylactic transfusion reactions. SMF Swiss Medical Forum. 2009;9(Suppl. 46):P174
    • Hustinx H, Niederhauser C, Gowland P, Still F, Lovey P, Fontana S. Requirements to the blood transfusion service in the case of a patient with multiple antibodies including a rare anti-Doa. SMF Swiss Medical Forum. 2009;9(Suppl. 46):P197
    • Reesink HW, Engelfriet CP, Schennach H, Gassner C, Wendel S, Fontão-Wendel R, de Brito MA, Sistonen P, Matilainen J, Peyrard T, Pham BN, Rouger P, Le Pennec PY, Flegel WA, von Zabern I, Lin CK, Tsoi WC, Hoffer I, Barotine-Toth K, Joshi SR, Vasantha K, Yahalom V, Asher O, Levene C, Villa MA, Revelli N, Greppi N, Marconi M, Tani Y, Folman CC, de Haas M, Koopman MW, Beckers E, Gounder DS, Flanagan P, Wall L, Aranburu Urtasun E, Hustinx H, Niederhauser C, Massey E, Gray A, Needs M, Daniels G, Callaghan T, Flickinger C, Nance SJ, Meny M. International Forum: Donors with a rare pheno (geno) type. Vox Sanguinis. 2008;95:236-253
    • Hustinx H, Poole J, Bugert P, Gowland P, Still F, Fontana S, Scharberg EA, Tilley L, Daniels G, Niederhauser C. The JAL(RH48) Antigen in Black and Caucasian Individuals: A Serological and Molecular Study. Transfusion Medicine. 2008;18: Suppl. 2: 21
    • Niederhauser C, Hustinx H, Gowland P, Still F, Mansouri Taleghani B, Fontana S, Thierbach J, Tissot JD, Maier A. Molecular RHD Screening of Serological Rh D Negative Swiss Blood Donors. Transfusion Medicine and Hemotherapy. 2008;35(suppl 1):16
    • Schütz A, Kurta V, Hustinx H, Mansouri Taleghani B, Niederhauser C, Fontana S. Comparison of Iso-Haemolysin and –Agglutinin Testing of Platelet Donors in the Context of the Prevention of Haemolytic Transfusion Reactions. Transfusion Medicine and Hemotherapy. 2008;35(suppl 1):70
    • Seltsam A, Strigens S, Levene C, Yahalom V, Moulds M, Moulds JJ, Hustinx H, Weisbach V, Figueroa D, Bade-Doeding C, Deluca DS, Blasczyk R. The molecular diversity of Sema7A, the semaphorin that carries the JMH blood group antigens. Transfusion. 2007;36:228-229
    • Chen Q, Hustinx H and Felgel WA. The RHCE allele ceSL: the second example for D antigen expression without D-specific amino acids. Transfusion. 2006;46:766-772
    • Poole J, Warke N, Hustinx H, Mansouri Taleghani BM, Martin P, Finning K, Crew VK, Green C, Bromilow I, Daniels G. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen. Transfusion. 2006;46:1879-85
    • Storry JR, Johannesson JS, Poole J, Strindberg J, Rodrigues MJ, Yahalom V, Levene C, Fujita C, Castilho L, Hustinx H, and Olsson ML. Identification of six new alleles at the FUT1 and FUT2 loci in ethnically diverse individuals with Bombay and Para-Bombay phenotypes. Transfusion. 2006;46:2149-2161
    • Flegel WA, Eicher NI, Doescher A, Hustinx H, Gowland P, Mansouri Taleghani B, Petershofen EK, Bauerfeind U, Ernst M, von Zabern I, Schrezenmeier H and Wagner FF. In-frame triplet deletions in RHD alter the D antigen phenotype. Transfusion. 2006;46:2156-2161
    • Hosseini-Maaf B, Irshaid NM, Hellberg A, Wagner T, Levene C, Hustinx H, Steffensen R, Chester MA, Olsson ML. New and unusual O alleles at the ABO locus are implicated in unexpected blood group phenotypes. Transfusion. 2005;45:70-81
    • Gassner C, Doescher A, Drnovsek TD, Rozman P, Eicher NI, Legler TJ, Lukin S, Garritsen H, Kleinrath T, Egger B, Ehling R, Kormoczi GF, Kilga-Nogler S, Schoenitzer D, Petershofen EK. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion. 2005;45:466-468
    • Mansouri Taleghani B, Meyer O, Fontana S, Ahrens N, Novak U, Borner MM, Salama A. Oxaliplatin-induced immune pancytopenia. Transfusion. 2005;45:704-8
    • Nydegger UE, Fontana S. Physiologie von Immunkomplexen. Teil 1. Swiss Medical Forum. 2005;5:335-340
    • Fontana S, Gadola S, Mansouri Taleghani B, Nydegger UE. Klinische Bedeutung von Immunkomplexen. Teil 2. Swiss Medical Forum. 2005;5:355-361
    • Matthes T, E Tullen, J Poole, J Banks, M Nagy, MJ Stelling, F Boehlen, M Michel, P Beris, H Hustinx, V Crew and G Daniels. Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti-IFC. Transfusion. 2002;42:1448-1457
    • Irshaid NM, NI Eicher, H Hustinx, J Poole and ML Olsson. Novel alleles at the JK blood group locus explain the absence of the erythrocyte urea transporter in European families. Br J Haematol. 2002;116:445-453
    • Wagner FF, NI Eicher , JR Jorgensen, CB Lonicer and WA Flegel. DNB: a partial D with anti-D frequent in Central Europe. Blood. 2002;100:2253-2256
    • Wagner FF, B Ladewig, KS Angert, GA Heymann, NI Eicher and WA Flegel. The DAU allele cluster of the RHD gene. Blood. 2002;100:306-311
    • Müller, TH, FF Wagner, A Trockenbacher, NI Eicher, WA Flegel, D Schönitzer, F Schunter and C Gassner. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion. 2001;41:45-52
    • Salama, A, P Schwind, K Schönhage, R Genth, C Cotting, H Hustinx, R Krieg, U Nydegger and I Aebischer. Rapid detection of antibodies to immunoglobulin A molecules by using the particle gel immunoassay. Vox Sanguinis. 2001;81:45-48
    • Wagner FF, A Frohmajer, B Ladewig, NI Eicher, CB Lonicer, TH. Müller, MH Siegel, and WA Flegel. Weak D alleles express distinct phenotypes. Blood. 2000;95:2699-2708

    Abstracts del Servizio regionale trasfusionale Bern

    • Lejon S, Gowland P, Fontana S, Niederhauser C and Hustinx H. Transfusion and Apheresis Science. DARA, a new DAR variant – serologic and molecular differences between DARA, weak D type 4.2.2, DV type 7, DARE and DAR. 2010; 43 (suppl. 1) S13: 23.
    • Thuresson B, Hosseini-Maaf B, Hult AK, Hustinx H, Chester MA and Olsson ML. A novel Bweak hybrid allele with a non-repeating CBF-enhancer region. Vox Sanguinis. 2010; 99 (suppl. 1): P-0735: 362.
    • Sigle JP, Hustinx H, Storry JR Olsson ML and Buser A. Mixed field agglutination in AB0 typing after allogeniec HSCT: influence of recipient secretor status. Vox Sanguinis. 2010; 99 (suppl. 1): P-0742: 365.
    • Hult AK, Yazer MH, Jorgensen R, Hellberg A, Palcic MM, Olsson ML, Peyrard T and Hustinx H. Weak A phenotypes associated with novel AB0 alleles carrying the A2 –related 1061C deletion and various missense amino acid substitutions. Vox Sanguinis. 99 (suppl. 1): P-0776: 377.
    • Venturelli D, Lunghi M, Baldini M, Hustinx H, Neri I, Mazza V and Montagnani G. Modulation of antibodies to Cromer Blood Group System antigens (anti Tcc(a)) and anti-Kidd (JKa) antibodies during late pregnancy. Transfusion. 2010; 50 (Suppl. S2): SP264: 156A.
    • Sigle JP, Boldanova T, Flückiger U, Infanti L, Rüfli T, Hustinx H and Buser A. Transfusion reaction due to coldagglutinins in a patient with Malaria. Swiss Medical Forum. 2010; 10 (Suppl. 50): P225:95 S.
    • Lejon S, Gowland P, Fontanan S, Niederhauser C and Hustinx H. A new DAR variant, DARA – serologic and molecular differences between DARA, Weak D type 4.2.2, Dv type 7, Dare and Dar. Transfusion Medicine. 2010; 20 (Suppl 1): S122: 12.
    • Green C, Bugert P, Hustinx H, Daniels G and Karamatic V. Crew. A silent mutation 939g> A in RHCE (Pro313) causes loss of a splice site and complete skipping of exon 6 resulting in expression of a novel E antigen. Transfusion Medicine. 2010; 20 (Suppl 1): PO20: 33.

    Pubblicazioni del Servizio regionale trasfusionale Vaud

    • Conne J, Schneider P, Tissot JD. Role of enzyme-treated cells in red blood cell antibody screening using the gel test: a study of anti-RH1, -RH2, and ?RH3 antibodies. J Clin Lab Anal. 2007;21:61-66

    Pubblicazioni del Servizio regionale trasfusionale Zürich

    • Antje Enekwe, Jutta Thierbach, Barbara Ziegler, Beat M. Frey. Erhöhte Inzidenz maligner hämatologischer Erkrankungen bei Blutspendern mit positivem direkten Antiglobulintest (DAT) Swiss Medical Forum, Supplementum 50, 2010;18(18)
    • C. Engström, B. Grossrieder, C. Gassner, B.M. Frey. Serology helps moleculardiagnostics to solve a rare case of Homozygous FY*X/FY*X - Consequences for Transfusion Recommendations. Transfusion and Apheresis Science, Vol. 43, Suppl. 1, S12, September 2010
    • A. Siderow, J. Ries, B. Grossrieder, J. Reichenbach, R. Seger, M. Hergersberger, B. Röthlisberger, B.M. Frey. Association of X-linked chronic granulomatous disease with the rare McLeod phenotype – a case report. 42. Jahreskongress der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI), Rostock. 2009
    • A. Siderow, J. Ries, B. Grossrieder, J. Reichenbach, R. Seger, M. Hergersberg, B.M. Frey. McLeod phenotype associated with X-linked chronic granulomatours disease: A liason with serious consequences. 77. Jahresversammlung der SGIM/SGH, Basel. 2009
    • M. Hergersberg, C. Ottiger, B.M. Frey, H.H. Jung, J. Reichenbach, R. Seger, B. Udd, J. Bruni, A.R. Huber, B. Röthlisberger. Characterization of X-chromosomal deletion in two patients with McLeod Syndrome by Array Comparative Genomic Hybridization. Swiss MedLab, Int. Congress, Montreux. September 16-19, 2008
    • M. Hergersberg, B. Röthlisberger, C. Ottiger, B.M. Frey, H.H. Jung, B. Udd, A.R. Huber. Characterization of a 1.7 Mb X-chromosomal deletion in a patient with McLeod Syndrome by Array CGH. 19. Jahreskongress der Deutschen Gesellschaft für Humangenetik. 2008
    • T. Dorn, B. Bader, A. Danek, H.H. Jung, Y. Achermann, B.M. Frey and G. Krämer. Seizures of extratemporal origin as a prominent feature in a Tamilian male with Chorea-Acanthocytosis. 27th Int. Epilepsy Congress Proceedings. Epilepsia. 2007;48 (Suppl. 7) p 473
    • Beat M. Frey, Monika Furrer, Pascale Jaquet. Molecular Genotyping of antithetical KEL polymorphisms by exontargeting PCR-RFLP. 40. Jahreskongress DGTI. 2007
    • Marcelo Miranda, Claudia Castiglioni, Martin Hergersberg, Adrian Danek, Hans H. Jung and Beat M. Frey. Phenotypic Variability of a Distinct Deletion in McLeod Syndrome. Mov Disord. 2007;Vol.22, No.9:1358-1361
    • Hans H. Jung, Adrian Danek and Beat M. Frey. MCLEOD SYNDROME - A NEURO-HEMATOLOGICAL DISORDER Vox Sanguinis. 2007;93:112-121
    • C.P. Engelfried, H.W. Reesink, G.F. Körmöczi, W.R. Mayr, S. Panzer, D. Schönitzer, R. Fontao-Wendel, S. Wendel, A. Long, M.H. Dziegiel, V. Kretschmer, R. Karger, F. Morelati, N. Revelli, M.A. Villa, M. Lai, M. de Haas, E. van der Schoot, M. Overbeeke, P. Maaskant, D. Gounder, P. Flanagan, G.B. Solheim, B. Zupanska, B. Michalewska, E. Muniz-Diaz, C. Martin-Vega, B.M. Frey, A. Mendez, S.A. Kochman, J.S. Epstein, G. Garratty, C. Lomas-Francis, C.M. Westhoff. Testing for weak D – International Forum. Vox Sanguinis. 2006;90:140-153
    • Christian Rüegg, Adriana Méndez, Edi Matheis, Annelies Böhlen-Bodmer and Beat M. Frey. Assignement of Lub-Negativity for rare donor selection requires sophisticated techniques based on molecular genotyping. Transfusion Medicine and Hemotherapy. Vol 32, Suppl 1, 2005;abstr P4.14, S.55
    • Adriana Méndez, Pascale Jaquet, Monika Furrer and Beat M. Frey. Quantification of D-Antigen density of weakD red blood cell phenotypes by flowcytometry. A rapid method to estimate the anti-D immunization risk. Swiss Medical Forum. Suppl. 23, 2005;May 11th, 22s, abstr S71
    • Adriana Méndez, Pascale Jaquet, Karin Hardegger, Annette Schille, Monika Furrer and Beat M. Frey. Prevalence and genotype of weakD red blood cell phenotypes in Swiss blood donors. Swiss Medical Forum. Suppl. 23, 2005;May 11th, 70s, P204 (abstr)
    • Edi Matheis, Annelies Böhlen-Bodmer, Karin Hardegger, Annette Schille and Beat M. Frey. Prevalence and specificity of blood group antibodies in Swiss blood donors. Transfusion Medicine and Hemotherapy. Vol 32, Suppl 1, 2005;abstr P4.12, S.54
    • H.H. Jung, M. Hergersberg, M. Vogt, J. Pahnke, V. Treyer, S.S. Kollias, D. Russo, B.M. Frey. McLeod Phenotype associated with a XK Missense Mutation without Hematological, Neuromuscular or Cerebral Involvement. Transfusion. 2003;Vol 43: 928-38
    • V. Ankelmann, B.M. Frey, M. Vogt, R. Eggmann, C. Janda, I. Galimberti, H.U. Lutz. Coombs-positive Red Blood Cells of Healthy Blood Donors carry Anti-C3/C3b Naturally Occurring Antibodies (Nabs). Swiss Medical Forum. Suppl 8, April 10, 2002;abstr 342.
    • B.M. Frey, M. Furrer, M. Vogt, M. Hergersberg, V. Treyer, S. Kollias, H.H. Jung. The G1016A XK Missense Mutation causes McLeod Immunophenotype without systemic Involvement. Vox Sanguinis. 2002;83, Suppl 2, P-072 (abstr)

    Marcatori infettivi

     

    Pubblicazioni del Servizio regionale trasfusionale Bern

    • Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low endemic region. Stolz M, Tinguely C, Graziani M, Fontana S, Gowland P, Buser A, Michel M, Canellini G, Züger M, Schumacher P, Lelie N and Niederhauser C. Transfusion Published Online: Jun 21 2010 DOI: 10.1111/j.1537-2995.2010.02732.x
    • 11 Jahre nationales Referenzzentrum für Infektionen durch Blut und Blutprodukte
      Niederhauser C. BAG Bulletin. 2010;10;336-344.
    • Fatal outcome of a hepatitis B virus transfusion-transmitted infection
      Niederhauser C, Weingand T, Candotti D, Maier A, Tinguely C, Wuillemin W.A, Gowland P, Allain J.P, Stolz M. Vox Sanguinis. 2010.
    • Niederhauser C, Ströhle A, Stolz M, Müller F, Tinguely C. The risk of a second diagnostic window with 4th generation HIV assays: Two cases. Journal of Clinical Virology. 2009;45:367-369
    • Tinguely C, Laeng B, Fontana S, Niederhauser C. Dépistage d'anticorps Plasmodium ssp par EIA en Suisse chez des donneurs de sang. Transfusion Clinique et Biologique, 24ième Congrès national de la SFTS Strasbourg. 2009;Vol.16-N3:P033
    • Stolz M, Weingand T, Maier A, Tinguely C, Gowland P, Wuillemin WA, Niederhauser C. A case of a fatal hepatitis B virus transfusion transmitted from an erythrocate concentrate with a very low viral load. Transfusion Medicine and Hemotherapy. 2009;36 (S1):P10.0
    • Hustinx H, Scholl N, Gowland P, Krieg R, Stolz M, Fontana S, Niederhauser C. Screening of Swiss blood donors for an IgA deficiency and its significance for the investigation of anaphylactic transfusion reactions. Schweiz Med Forum. 2009;9 (Suppl.46)
    • Schüpbach J, Niederhauser C, Yerly S, Regenass S, Matter L, Bürgisser P, Gorgievski M, Steffen I, Andreutti C, Schultze D, Martinetti G, Schulze S, Gebhardt M. SÖDAK. Line-immunoassay-based differentiation of recent and older HIV-1 infection among all newly diagnosed patients in Switzerland. (Deutsch-Schweiz-Österreichischer AIDS Kongress). 2009;P304
    • Stolz M, Tinguely C, Graziani M, Fontana S, Niederhauser C. Individual nucleic acid testing detects hepatitis B window phase and chronic occult hepatitis in Switzerland: a low endemic region. Swiss Society for Microbiology: 68th Annual Assembly of the SSM. 2009;P107
    • Niederhauser C, Müller F, Ströhle A, Tinguely C. The risk of a second diagnostic window with 4th generation HIV assays: two cases. Swiss Society for Microbiology: 68th Annual Assembly of the SSM. 2009;P109
    • Niederhauser C, Mansouri Taleghani B, Graziani M, Stolz M, Tinguely C, Schneider P. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus? Swiss Med Wkly. 2008;138(9-10):134-141
    • Reesink HW, Engelfriet C.P, Henn G, Mayr W.R, Delage G, Bernier F, Krusius T, Assal A, Gallian P, Corbi C, Morel P, David B, De Micco P, Murokawa H, Yugi H, Hino S, Tadokoro K, Fiesland O, Brojer E, Letowska M, Olim G, Nascimento F, Gonçalves H, Castro L, Morais M, Stezinar S.L, Alvarez M, Sauleda S, Gonzàlez R, Niederhauser C, Stolz M, Allain J.P, Owusu-Ofori S, Eglin R, Stramer S, Busch M, Strong D.M, Epstein J, Biswas R. International Forum: Occult hepatitis B infection in blood donors. Vox Sanguinis. 2008;94:153-166
    • Niederhauser C, Stolz M, Graziani M, Tinguely C, Fontana S. Individual Nucleic Acid Testing (ID-NAT) in Swiss Blood Donors: A Low Endemic Hepatitis B Virus (HBV) Area. Transfusion Medicine and Hemotherapy. 2008;35(suppl 1):46
    • Niederhauser C, Schneider P, Fopp M, Ruefer A and Lévy G. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003. Eurosurveillance monthly 2005;10: 7-8
    • Coste J, Reesink HW, Engelfriet CP, Laperche S, Brown S, Busch MP, Cuijpers HT, Elgin R, Ekermo B, Epstein JS, Flesland O, Heier HE, Henn G, Hernandez JM, Hewlett IK, Hyland C, Keller AJ, Krusius T, Levicnik-Stezina S, Levy G, Lin CK, Margaritis AR, Muylle L, Niederhauser C, Pastila S, Pillonel J, Pineau J, van der Poel CL, Politis C, Roth WK, Sauleda S, Seed CR, Sondag-Thull D, Stramer SL, Strong M, Vamvakas EC, Velati C, Vesga MA, Zanetti A. International forum 1. Vox Sang. 2005;88:289-298
    • Boni J, LR Bisset, JJ Burckhardt, HI Joller-Jemelka, P Burgisser, L Perrin, M Gorgievski, P Erb , W Fierz, JC Piffaretti, J Schupbach; Swiss HIV Cohort Study. Prevalence of human T-cell leukemia virus types I and II in Switzerland. J Med Virol. 2004;72:328-37
    • Gowland P, Fontana S, Niederhauser C and Mansouri Taleghani B. Molecular and serological tracing of a transfusion-transmitted hepatitis A virus. Transfusion. 2004;44:1555-1561
    • Stolz M, Gilgen M  and Niederhauser C. HCV-PCR Minipool Testing – 3 Years in the Largest Swiss Blood Transfusion Service. Vox Sanguinis. 2003;84:105-110
    • Niederhauser C and Kaempf L. Improved Sensitivity of the Chlamydia trachomatis Cobas Amplicor Using an Optimized Procedure for Preparation of Specimens . Eur. J. Clin. Microbiol. Infect. Dis. 2003;22:118-121
    • Baum H, T Bertsch, J Bohner, KW von Pape, T Hoff, B. Wilke, N Katz, H Luthe, H Luz, D Nagel, C Niederhauser, RHN van Schaik, Ch Aschenneller, I Schulz and R Zerback. Detection Limit, Cut-off and Specificity of an Improved Rapid Assay for Cardiac Troponin T. Clinical Laboratory. 2001;47:549-554
    • Niederhauser C. Ist die Diagnose einer konatalen Zytomegalie Infektion im Nachhinein in der Schweiz möglich? Paediatrica. 2000;11:43-44
    • Niederhauser C, Kaempf L and Heinzer I. Use of the Ligase Detection Reaction-Polymerase Chain Reaction to Identify Point Mutations in Extended Spectrum Beta-Lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 2000;19:477-480

    Abstracts del Servizio regionale trasfusionale Bern

    • First case of HIV window donation in Switzerland after 8 years of universal HIV NAT screening. Gottschalk J, Achermann Y, Niederhauser C, Tinguely C, Glauser A, Lodemann P and FreyBM. Transfusion and Apheresis Science. 2010; 43, (suppl. 1) S25: 27.
    • Fatal outcome of a hepatitis B Virus transfusion-transmitted infection. Niederhauser C, Weingand T, Maier A, Wuillemin WA ,Tinguely C, Gowland P and Stolz M. Transfusion and Apheresis Science. 2010; 43, (suppl. 1) S26: 25.
    • Multicenter study of the new highly sensitive and specific Enzygnost HBSAG 6.0 assay. Schobel U, Dengler T, Doerr HW, Echevarria JM, Gerlich WH, Gottschalk J, Graziani M, Karl A, Schottstedt V, Wagner F, Weber B, Weik M, Weissbrich B, Willems WR and Nick S. Vox Sanguinis. 2010; 99 (suppl. 1): P-0536: 290.
    • Lessons learned form Parvovirus B19 infections in Swiss Blood Donors. Niederhauser C, Stolz M, Mauchle P and Fontana S. Vox Sanguinis. 2010; 99 (suppl. 1): P-0614: 318
    • Fatal outcome of a Hepatitis B Virus transfusion-transmitted infection. Niederhauser C, Weingand T, Maier A, Wuillemin WA, Tinguely C, Gowland P and Stolz M. Swiss Society for Microbiology: 69th Annual Assembly of the SSM. 2010; P139: 221.
    • Frequency and characteristics of Parvovirus B19 infections in Swiss Blood Donors. Niederhauser C, Stolz M, Mauchle P, Gowland P and Fontana S. Swiss Society for Microbiology: 69th Annual Assembly of the SSM. 2010; P140: 222.

    Pubblicazioni del Servizio regionale trasfusionale Vaud

    • Niederhauser C, Schneider P, Fopp M, Ruefer A, Levy G. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003. Euro Surveill. 2005;10:14-16 (IF inconnu)

    Pubblicazioni del Servizio regionale trasfusionale Zürich

    • U. Schobel, T. Dengler, HW. Doerr, JM. Echevarria, WH. Gerlich, J. Gottschalk, M. Graziani, A. Karl, V. Schottstedt, F. Wagner, B. Weber, M. Weik, B. Weissbrich, WR. Willems, S. Nick. Multicenter Study of the new highly sensitive and specific Enzygnost HBSAG 6.0 Assay. Vox Sanguinis, Vol. 99, Suppl. 1, July 2010
    • J. Gottschalk, Y. Achermann, C. Niederhauser, C. Tinguely, A. Glauser, P. Lodemann, B.M. Frey. First Case of HIV Window Donation in Switzerland after 8 Years of Universal HIV NAT Screening. Transfusion and Apheresis Science, Vol. 43, Suppl. 1, S25, September 2010
    • A. Glauser, K. Hardegger, J. Gottschalk and Beat M. Frey. Four parameter NAT screening by Taqscreen MPW with Cobas s201 in Switzerland: validation, implementation, and first experiences. XIXth Regional Congress of the ISBT, Eastern Mediterranean and Europe, Cairo, Egypt. 2009
    • A. Glauser, K. Hardegger, J. Gottschalk, B.M. Frey. Five parameter NAT screening by Taqscreen MPX with Cobas s201 in Switzerland: validation, implementation and first experiences. 42. Jahreskongress der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI), Rostock. 2009
    • Edi Matheis, Annelies Böhlen-Bodmer, Barbara Grossrieder and Beat M. Frey. Remaining red blood cell allo-antibodies in blood products donated by allo-sensitized blood donors. A comparative titration study. Forum Med Suisse. 2006;6: (Suppl 30), S 62
    • Beat M. Frey, Nurhak Dogan, Pascale Jaquet and Monika Furrer. D antigen density and D zygosity of reagent red cells are not determinant for anti-D semiquantification by standard serology titration techniques. Forum Med Suisse. 2006;6: (Suppl 30), S63
    • Beat M Frey, Edi Matheis, A. Böhlen-Bodmer, B. Grossrieder.Prevalence, specificity and titre of allo-antibodies in voluntary blood donations and in the corresponding blood products. Vox Sanguinis. 2006;91: Supp.3, P-424
    • Inga Hegemann, Pascale Jaquet, Monika Furrer and Beat M. Frey. Genotypic and phenotypic characterization of Dombrock (Do) blood group antigens in blood donors. Transfusion Medicine and Hemotherapy. 2006;Vol. 33 (Suppl. 1), abstr. P6.15, S 46
    • Edi Matheis, Barbara Grossrieder, Anna E. Böhlen-Bodmer, Monika Furrer and Beat M. Frey. Allocation of transfusion compatible red blood cell concentrates in the presence of warm-reactive antibodies – a retrospective comparison of two different strategies. Transfusion Medicine and Hemotherapy. 2006;Vol. 33 (Suppl. 1), abstr. P6.13, S 46
    • Velia Alaia, Beat Frey, and Hans U. Lutz. Coombs-positive red blood cells in healthy blood donors, an evidence-based explanation. Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Hämatologie und Onkologie Leipzig. 2006
    • Axel Rüfer, Karin Bracher, Adrian Röthlisberger, Gürcan Yavuzcan and Beat M. Frey. Should we change our current practice of blood donor screening in Switzerland? The ALAT data. Swiss Medical Forum. Suppl. 23, 2005;May 11th, 69s, P200 (abstr)
    • A. Méndez, A. Rüfer and B.M. Frey. Significance of confirmatory testing of blood donors with positive screening findings for anti-HIV and anti-HCV. Swiss Medical Forum. Suppl 17, 2004;April 28, 36s, abstr 239
    • M. Siroky, A. Glauser, S. Rosamilia, B.M. Frey. HCV-RNA Screening of Swiss Blood Donors is Redundant to Established Surrogate Marker Testing. Swiss Medical Forum. Suppl 12, 2003;Mai 7, 35s, abstr. 205

    Prodotti sanguigni - Controllo di qualità

     

    Pubblicazioni del Servizio regionale trasfusionale Basel

    • Heim D, Passweg J, Gregor M, Buser A, Theocharides A, Arber C, Meyer-Monard S, Halter J, Tichelli A, Gratwohl A. Patient and product factors affecting platelet transfusion results. Transfusion. 2008 Apr;48(4):681-7

    Pubblicazioni del Servizio regionale trasfusionale Bern

    • Niederhauser C. Editorial. pipette (Sonderheft Transfusionsmedizin). 2009;4:8
    • Julmy F, Ammann RA, Mansouri Taleghani B, Fontana S, Hirt A, Leibundgut K. Effects of high-yield thrombocytapheresis on the quality of platelet products. Transfusion. 2008;48:442-50
    • Mansouri Taleghani B, Fontana S, Nydegger UE. Leucodepletion of red cells: current techniques and improvement of whole blood storage quality. In: Rossi U, de Villaescusa (eds.) Universal leucodepletion: the European experience. Edition SIMTI, Milano, Italy. 2003;73-81

    Abstracts del Servizio regionale trasfusionale Bern

    • An evaluation of preventive measures to reduce the risk of Trali after transfusion of single donor apheresis platelets in Switzerland.  Fontana S, Thierbach J, Muriset M, Sigle J, Gowland P, Niederhauser C, Sunic K, Infanti L, and Buser A. Transfusion and Apheresis Science. 2010; 43 (suppl. 1) S13: 17.
    • Trali-safe platelets: an evaluation of preventive measures to reduce the risk of Trali after transfusion of single donor apheresis platelets in Switzerland. Fontana S, Thierbach J, Muriset M, Sigle J, Gowland P, Niederhauser C, Sunic K, Infanti L and Buser A. Vox Sanguinis. 2010; 99 (suppl. 1): P-0999: 454.
    • Effects of a simple guideline for transfusion of red blood cells (RBC) in elective hip and knee replacement on blood supply and costs. Fontana S, Müller U, Perler M, Krummen L, Läderach A, De La Cuadra C, Luginbühl M and Mansouri Taleghani B. Swiss Medical Forum. 2010; 10 (Suppl. 50): PFM51: 19 S.
    • Trali-safe platelets: An evaluation of preventive measures to reduce the risk of Trali after transfusion of single donor apheresis platelets in Switzerland. Fontana S, Thierbach J, Muriset M, Sigle J, Gowland P, Niederhauser C, Sunic K, Infanti L and Buser A. Swiss Medical Forum. 2010; 10 (Suppl. 50): P226: 96 S
    • Optimizing collection quality and efficacy for high yield plateletpheresis in the planification of a clinical trial. Fontana S, Summermatter R, Gerber R, Vogt M, Mansouri Taleghani B, Barmettler D, Agerter P, Payrat JM. Vox Sanguinis. 2010; 99 (suppl. 1) P-0215: 169.

    Pubblicazioni del Servizio regionale trasfusionale Zürich

    • Beat M. Frey, E. Skalsky, M. Frey-Wettstein. Universal leucodepletion of blood products in Switzerland: a retrospective analysis of quality assurance data. Swiss Medical Forum. Suppl. 17, 2004;April 28, 91s, abstr P536
    • E. Skalsky, B.M. Frey. Die Vollblutfiltration in der Schweiz: Eine retrospektive Untersuchung von Qualitätsaspekten anhand der Validierungsdaten von 7 Regionalen Blutspendedienste. Inauguraldissertation an der Medizinischen Fakultät Zürich. 2003
    • Beat M. Frey and Monica Furrer-Burger. Enumeration of residual cells in leukodepleted blood products: techniques and pitfalls. in Universal leucodepletion: the European experience, U. Rossi and R.Garcia de Villaescusa (ed), Edizioni SIMTI, Milano. 2003;105-116
    • B.M. Frey, M. Furrer, M. Frey-Wettstein. Reproducible Quantification of Residual White Blood Cells in Leukodepleted Blood Products by Flowcytometry over more than 5 Days. Swiss Medical Forum. Suppl 8, April 10, 2002;abstr 344

    Applicazioni cliniche

     

    Pubblicazioni del Servizio regionale trasfusionale Basel

    • Buser A, Sigle J, Halter J. Blood transfusions in the treatment of chronic anemia.Ther Umsch. 2010 May;67(5):265-9. German
    • Weber WP, Zwahlen M, Reck S, Misteli H, Rosenthal R, Buser AS, Kaufmann M, Oertli D, Widmer AF, Marti WR. The association of preoperative anemia and perioperative allogeneic blood transfusion with the risk of surgical site infection. Transfusion. 2009 Sep;49(9):1964-70. Epub 2009 May 11.

    Pubblicazioni del Servizio regionale trasfusionale Bern

    • Regli B, Mansouri Taleghani B. Erythrozytentransfusion im Jahr 2008 – intensiv-medizinische Aspekte. pipette (Sonderheft Transfusionsmedizin). 2009;4:26-27
    • Mansouri Taleghani B, Müller U, Fontana S. Erythrozytentransfusion im Jahr 2008 – intensiv-medizinische Aspekte. pipette (Sonderheft Transfusionsmedizin). 2009;4:28-30
    • Fontana S, Weingand T, Maier A, Mansouri Taleghani B. Prospective, Paired Crossover Comparison of the in vitro Quality of Red Blood Cells Collected by the Automate for Blood Collection Device or by a Conventional Method. Transfusion Medicine and Hemotherapy. 2009;36:289-292
    • Julmy F, Ammann RA, Mansouri Taleghani B, Fontana S, Hirt A, Leibundgut K. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs. Transfusion. 2009;49:21-33
    • Fontana S, Müller U, Perler M, Lädrach A, Krummen L, de la Cuadra C, Luginbühl M, Mansouri Taleghani B. A Simple Guideline Reduces the Need for Red Blood Cell (RBS) Transfusions: A Prospective, Multicenter, Before-and-after Study in Elective Hip and Knee Replacement. Transfusion Medicine and Hemotherapy. 2009;36 (S1):P4.04
    • Fontana S, Müller U, Perler M, Eberle B, Regli B, Schmidli J, Carrel T, Krummen L, Lädrach A, Mansouri Taleghani B. Red Blood Cell (RBC) Use in Elective Cardiac and Vascular Surgery: A Prospective Assessment of the Effect of a Transfusion Guideline in a Swiss University Hospital. Transfusion Medicine and Hemotherapy. 2009;36 (S1):P4.05
    • Fontana S, Müller U, Staub L, Luginbühl M, Kwasna M, Schmid P, Krummen L, Lädrach A, de la Cuadra C, Mansouri Taleghani B. Implementation of Transfusion Guidelines for Red Blood Cells (RBC) in Elective Hip and Knee Replacement: A Prospective, Multicenter, Before-and-after Study in 10 Swiss Hospitals. Transfusion Medicine and Hemotherapy. 2008;35(suppl 1):76-77
    • Fontana S, Müller U, Staub L, Eberle B, Regli B, Carrel T-P, Schmidli J, Kwasna M, Schmit P, Mansouri Taleghani B. Red Blood Cell (RBC) Use in Elective Cardiac and Vascular Surgery: A Prospective Assessment Prior to the Implementation of Transfusion Guidelines in a Swiss University Hospital. Transfusion Medicine and Hemotherapy. 2008;5(suppl 1):77
    • Fontana S, Kremer Hovinga JK, Lämmle B, Mansouri Taleghani B. Treatment of thrombotic thrombocytopenic purpura. Vox Sanguinis. 2006;90:245-254
    • Fontana S, Kremer Hovinga JA, Studt JD, Alberio L, Lämmle B, Mansouri Taleghani B. Plasma therapy in thrombotic thrombocytopenic purpura: Review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency. Seminars in Hematology. 2004;41:48-59
    • Kremer Hovinga JA, Studt JD, Demarmels Biasiutti F, Solenthaler M, Alberio L, Zwicky C, Fontana S, Mansouri Taleghani B, Tobler A, Lämmle B. Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura. Haematologica. 2004;89:320-324

    Pubblicazioni del Servizio regionale trasfusionale Vaud

    • Madjpour C, Marcucci C, Tissot JD, Spahn DR: Perioperative Bluttransfusion – Nutzen, Risken und Richtlinien. Anaesthesist, 2005;54:67-80 (IF 0.849)
    • Siegenthaler M.A, Rosselet A, Tissot JD. Quels risques transfusionnels en 2003 ? Partie 2 : les risques émergeants, les risques de la thérapie transfusionnelle et l’hémovigilance. Médecine et Hygiène. 2004;62:1297-1301
    • Hohlfeld P, Marty F, De Grandi P, Tissot JD, Bossart H: Le Livre de l’Interne. Obstétrique. Paris, Flammarion, 3ème édition, 2004;pp 1-384
    • Siegenthaler M.A., Tissot JD, Rosselet A. Quels risques transfusionnels en 2003 ? Partie 1 : Les risques liés aux produits sanguins. Médecine et Hygiène. 2003;61:2478-2481

    Pubblicazioni del Servizio regionale trasfusionale Zürich

    • Peter Lodemann, Judith Ries, Georg Schorer, Beat M. Frey. Iron Depletion Dynamics and Safety of Therapeutic Erythrocytapheresis versus Conventional Phlebotomy in Patients with Haemochromatosis. Vox Sanguinis, Vol. 99, Suppl. 1, July 2010
    • P. Lodemann, J. Ries, G. Schorer, B.M. Frey. Prospective Comparison Efficacy of Therapeutic Apheresis versus Conventional Phlebotomy - Preliminary data from Hemochromatosis Patients. Transfusion and Apheresis Science, Vol. 43, Suppl. 1, S25, September 2010
    • R.N.I. Pietersz, C.P. Engelfried,H.W. Reesink, K.G.Davis, J. Lown, A. Thomson, P. Turek, E. Dickmeiss, T. Krusius, J. Matilainen, V. Kretschmer, R. Karger, P. Reinhardt, M. Wiesneth, H. Schrezenmeier, E. Seifried, P. Rebulla, N. Greppi, D. Riccardi, F. Molrelati, M. Uchikawa, N.H. Tsuno, K. Takahashi, K. Tadokoro, V.M.J. Novotny, A. Brand, B.G. Solheim, B. Zupanska, M. Lozano, J. Cid, R. Mazzara, F. Knutson, R. Norda, B.M. Frey, S. MacLennan, J.M. Heal, N. Blumberg. Transfusion of apheresis platelets and ABO groups – International Forum. Vox Sanguinis. 2005;88:2007 – 221

    Terapie cellulari – Trapianto – Cellule staminali

     

    Pubblicazioni del Servizio regionale trasfusionale Aargau/Solothurn

    • A.Gratwohl, H.Baldomero, O.Schmid, B.Horisberger, M.Bargetzi, A.Urbano-Ispizua. Special report: Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe. A report of the EBMT activity survey 2003. Bone Marrow Transplantation. 2005;36:575-590
    • MA.Siegenthaler, DH.Vu, M.Ebnöther, N.Ketterer, F.Lüthi, P.Schmid, M.Bargetzi, D.Gasparini, JD.Tissot. „Agglutination and flocculation“ of stem cells collected by apheresis due to cryofibrinogen. Bone Marrow Transplantation. 2004;33:765-767
    • Report of the Research Group on Cellular Immune Therapies (SP-CIT): The Provision of Safe Products Meeting High Quality Standards. Council of Europe. 16-17. Nov. 2004
    • M.J.Bargetzi, J.Passweg, E.Baertschi, A.Schoenenberger, C.Gwerder, A.Tichelli, J.Burger, W.Mingrone, R.Herrmann, A.Gratwohl and M.Wernli. Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective. Bone Marrow Transplantation. 2003;31:99-103

    Pubblicazioni del Servizio regionale trasfusionale Basel

    • Gerull S, Arber C, Bucher C, Buser A, Gratwohl A, Halter J, Heim D, Tichelli A, Stern M. Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCT.Bone Marrow Transplant. 2010 Aug 9. [Epub ahead of print]
    • Cantoni N, Gerull S, Heim D, Halter J, Bucher C, Buser A, Tsakiris DA, Passweg J, Tichelli A, Stern M, Gratwohl A.
      Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT. Bone Marrow Transplant. 2010 Jun 14. [Epub ahead of print]
    • Cantoni N, Hirsch HH, Khanna N, Gerull S, Buser A, Bucher C, Halter J, Heim D, Tichelli A, Gratwohl A, Stern M. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease.Biol Blood Marrow Transplant. 2010 Mar 27. [Epub ahead of print]
    • Stoffel N, Rysler C, Buser A, Gratwohl A, Tsakiris DA, Stern M. Leukocyte count and risk of thrombosis in patients undergoing haematopoietic stem cell transplantation or intensive chemotherapy. Thromb Haemost. 2010 Jun;103(6):1228-32. Epub 2010 Mar 29.
    • Leitner G, Panzer S, Reesink HW, Stiegler G, Fischer-Nielsen A, Dickmeiss E, Einsele H, Reinhardt P, Schrezenmeier H, Wiesneth M, Coluccia P, Nygell UA, Halter J, Sigle J, Gratwohl A, Buser AS, Ozturk G, Anak S. Preparation of granulocyte concentrates by apheresis. Vox Sang. 2010 Mar 10. [Epub ahead of print] No abstract available.
    • N. Worel, S. Panzer, H. W. Reesink, W. Linkesch, E. Dickmeiss, A. Fischer-Nielsen, K. Hölig, D. Stachel, R. Zimmermann, W. Holter, P. Coluccia, D. Brilhante, E. Watz, J.-P. Sigle, A. Gratwohl, A. Buser, O. Arslan, F. Regan, M. Edwards Transfusion policy in ABO-incompatible allogeneic stem cell transplantation. Vox Sanguinis Volume 98, Issue 3, Date: April 2010, Pages: 455-467
    • Kalaycio ME, Kukreja M, Woolfrey AE, Szer J, Cortes J, Maziarz RT, Bolwell BJ, Buser A, Copelan E, Gale RP, Gupta V, Maharaj D, Marks DI, Pavletic SZ, Horowitz MM, Arora M. Allogeneic Hematopoietic Cell Transplant for Prolymphocytic Leukemia. Biol Blood Marrow Transplant. 2010 Apr;16(4):543-7. Epub 2009 Dec 2.
    • Stussi G, Halter J, Tichelli A, Meyer-Monard S, Buser AS, Arber C, Heim D, Passweg JR, Rischewski J, Paulussen M, Gratwohl A. Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies. Bone Marrow Transplant. 2010 Jan;45(1):103-9. Epub 2009 Jun 29.
    • Cantoni N, Weisser M, Buser A, Arber C, Stern M, Heim D, Halter J, Christen S, Tsakiris DA, Droll A, Frei R, Widmer AF, Flückiger U, Passweg J, Tichelli A, Gratwohl A. Infection prevention strategies in a stem cell transplant unit: Impact of change of care in isolation transplant related mortality. Eur J Haematol. 2009 Aug;83(2):130-8. Epub 2009 Mar 5.
    • Stalder MP, Rovó A, Halter J, Heim D, Silzle T, Passweg J, Rischewski J, Stern M, Arber C, Buser A, Meyer-Monard S, Tichelli A, Gratwohl A. Aplastic anemia and concomitant autoimmune diseases. Ann Hematol. 2009 Jul;88(7):659-65. Epub 2009 Jan 13.
    • Oettl T, Halter J, Bachmann A, Guerke L, Infanti L, Oertli D, Mihatsch M, Gratwohl A, Steiger J, Dickenmann M. ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies. Nephrol Dial Transplant. 2009 Jan;24(1):298-303. Epub 2008 Aug 26.
    • A. Buser,  M. Stern, C. Arber,  M. Medinger, J. Halter, A. Rovo, G. Favre, A. Lohri,  A. Tichelli, A. Gratwohl Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pre- treatment with rituximab? Bone Marrow Transplant. 2008 Oct;42(7):483-7.
    • Hambach L, Vermeij M, Buser A, Aghai Z, van der Kwast T, Goulmy E. Targeting a single mismatched minor histocompatibility antigen with tumor-restricted expression eradicates human solid tumors. Blood. 2008 Sep 1;112(5):1844-52. Epub 2008 Jun 10.
    • Rovó A, Daikeler T, Stern M, Halter J, Studt JD, Buser A, Heim D, Rischewski J, Medinger M, Tyndall A, Gratwohl A, Tichelli A. Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis. Blood. 2008 111:1740-1
    • Arber C, Buser A, Heim D, Weisser M, Tyndall A, Tichelli A, Passweg J, Gratwohl A. Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment. Bone Marrow Transplant. 2007 Sep;40(6):597-8.
    • Bucher C, Stern M, Buser A, Heim D, Paulussen M, Halter J, Tsakiris D, Droll A, Meyer-Monard S, Tichelli A, Passweg J, Gratwohl A. Role of primacy of birth in HLA-identical sibling transplantation. Blood. 2007 Jul 1;110(1):468-9.
    • AS Buser, M Stern, C Bucher, C Arber, D Heim, J Halter, S Meyer-Monard, G Stussi, A Lohri, M Ghielmini, A Tichelli, JR Passweg, A Gratwohl High Dose Chemotherapy using BEAM without autologous rescue followed by reduced intensity conditioning allogeneic stem cell transplantation for refractory or relapsing lymphomas - a comparison of delayed versus immediate transplantation Bone Marrow Transplant. 2007 Mar;39(6):335-40.
    • Martinez MT, Bucher C, Stussi G, Heim D, Buser A, Tsakiris DA, Tichelli A, Gratwohl A, Passweg JR. Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoetic stem cell transplants. Bone Marrow Transplant. 2005 Dec;36(11):993-1000.
    • AS Buser, D Heim, C Bucher , A Tichelli ,A Gratwohl and JR Passweg High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma. Bone Marrow Transplant. 2004 May;33(10):1011-4

    Pubblicazioni del Servizio regionale trasfusionale Bern

    • Zahnd D, Leibundgut K, Zenhausern R, Pabst T, Fontana S, Schneider R, Tobler A, Zwicky C. Implementation of the JACIE standards for a haematopoietic progenitor cell transplantation programme: a cost analysis. Bone Marrow Transplant. 2004;34:847-53

    Pubblicazioni del Servizio regionale trasfusionale Zürich

    • Zoltan Banki, Wilfried Posch, Asim Ejaz, Verena Oberhauser, Suzanne Willey, Christoph Gassner, Heribert Stoiber, Ulf Dittmer, Manfred P. Dierich, Kim J. Hasenkrug, Doris Wilflingseder. Complement as an Endogenous Adjuvant for Dendritic Cell-mediated Induction of Retrovirus-specific CTLS. PLoS Pathogens, Vol. 6, Issue 4, April 2010

    Vigilanza

     

    Pubblicazioni del Servizio regionale trasfusionale Vaud

    • Tissot JD. Prevention and diagnosis of delayed haemolytic transfusion reactions. Vox Sang. 2006;91:363-365 (IF : 1.888)
    • Madjpour C, Marcucci C, Tissot JD, Spahn DR. Perioperative Bluttransfusion – Nutzen, Risken und Richtlinien. Anaesthesist. 2005;54:67-80 (IF 0.849)
    • Siegenthaler M.A, Vu DH, Schneider P, Tissot JD. Haemovigilance in a general university hospital: need for a more comprehensive classification and a codification of transfusion related events. Vox Sanginis. 2005;88:22-30 (IF : 1.888)

    Pubblicazioni del Servizio regionale trasfusionale Zürich

    • B.M. Frey, Barbara Grossrieder, Antigony Nikos und Peter Lodemann. Anti-HLA/PA-Antibodies in Female Blood Donors depend on Gravidity Status and remain Life-long. Swiss Medical Forum, Supplementum 50, 2010;10(18

    Informatica

     

    Pubblicazioni del Servizio regionale trasfusionale Vaud

    • Abonnenc M, Dayon L, Peruche B, Lion N, Girault HH. Electrospray micromixer chip for on-line derivatization and kinetic studies. Analytical Chemistry. 2008;80:3372-3378
    • Prudent M, Rossier JS, Lion N, Girault HH. Microfabricated dual sprayer for on-line mass tagging of phosphopeptides. Analytical Chemistry. 2008;80:2531-2538
    • Bobos A, Boecker W, Childers R, Couture A, Davis R, Espensen L, Fournier S, Holcombe J, Hulleman R, Lupo B, McDonnell S, Mokros I, Munk C, Steinke W, Wurzbach T. ISBT guidelines for information security in transfusion medicine. Vox Sang. 2006;91 Suppl 1:S1-23 (IF : 1.888)
    • Nobile M, Correa R, Borghans JA, D'Agostino C, Schneider P, De Boer RJ, Pantaleo G; Swiss HIV Cohort Study. De novo T-cell generation in patients at different ages and stages of HIV-1.disease. Blood. 2004;104:470-477 (IF : 9.782)
    • Bocker W, Clark M, Desaint C, Davis R, Distler P, Izaguirre C, Kawaters A, Lupo B, McDonnell S, Munk C, Nozick R; ISBT. ISBT - Guidelines for validation and maintaining the validation state of automated systems in blood banking. Vox Sang. 2003;85 Suppl 1:S1-14 (IF : 1.888)

    Vari temi

     

    Pubblicazioni del Servizio regionale trasfusionale Aargau/Solothurn

    • Witt H, Sahin-Toth M, Landt O, Chen JM, Kahne T, Drenth JP, Kukor Z, Szepessy E, Halangk W, Dahm S, Rohde K, Schulz HU, Le Marechal C, Akar N, Ammann RW, Truninger K, Bargetzi M, Bhatia E, Castellani C, Cavestro GM, Cerny M, Destro-Bisol G, Spedini G, Eiberg H, Jansen JB, Koudova M, Rausova E, Macek M, Malats N, Real FX, Menzel HJ, Moral P, Galavotti R, Pignatti PF, Rickards O, Spicak J, Zarnescu NO, Bock W, Gress TM, Friess H, Ockenga J, Schmidt H, Pfutzer R, Lohr M, Simon P, Weiss FU, Lerch MM, Teich N, Keim V, Berg T, Wiedenmann B, Luck W, Groneberg DA, Becker M, Keil T, Kage A, Bernardova J, Braun M, Guldner C, Halangk J, Rosendahl J, Witt U, Treiber M, Nickel R, Ferec C. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet. 2006;38:668-673
    • M.Treiber, HU.Schulz, O.Landt, JP.Drenth, C.Castellani, FX.Real, N.Akar, RW.Ammann, M.Bargetzi, E.Bhatia, AG.Demaine, G.Destro-Bisol, C.Battagia, A.Kingsnorth, D.O’Reilly, K.Truninger, M.Koudova, M.Macek Jr, J.Spicak, M.Cerny, HJ.Menzel, P.Moral, PF.Pignatti, MG.Romanelli, O.Rickards, GF.De Stefano, NO.Zarnescu, G.Choudhuri, SS.Sikora, JB.Jansen, FU.Weiss, M.Pietschmann, N.Teich, TM.Gress, J.Ockenga, H.Schmidt, A.Kage, J.Halangk, J.Rosendahl, DA.Groneberg, R.Nickel, H.Witt. Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer. J Mol Med. 2006;84:1015-1022
    • V.Dittmann, M.Bargetzi, A.Bondolfi, B.Elger, M.Gersbach-Forrer, H.Kurz, W.Pletscher, M.Salathé, H.Schneider, D.Sprumont, E.Stauffer, M.Vallotton. Biobanken: Gewinnung, Aufbewahrung und Nutzung von menschlichem biologischen Material. SAMW Medizinisch-ethische Richtlinien und Empfehlungen. Schweiz. Aerztezeitung. 2006;87:1024-1029
    • M.Verlaan, JPH.Drenth, K.Truninger, M.Koudova, H-U.Schulz, M.Bargetzi, B.Künzli, H.Friess, M.Cerny, A.Kage, O.Landt, RHM.te Morsche, J.Rosendahl, W.Luck, R.Nickel, J.Halangk, M.Becker, M.Macek Jr., JBM.Jansen, H.Witt. Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases. J Med Genet. 2005;42:e62
    • V.Beyer, C.Castagné, D.Mühlematter, V.Parlier, J.Gmür, U.Hess, T.Kovacsovics, S.Meyer-Monard, A.Tichelli, A.Tobler, E.Jacky, U.Schanz, M.Bargetzi, A.Hagemeijer, T.de Witte, G.van Melle and M.Jotterand. Systematic screening at diagnosis of -5/del(5)(q31), -7 or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics. Cancer Genet Cytogenet. 2004;152:29-41

    Pubblicazioni del Servizio regionale trasfusionale Basel

    • Reichlin T, Socrates T, Egli P, Potocki M, Breidthardt T, Arenja N, Meissner J, Noveanu M, Reiter M, Twerenbold R, Schaub N, Buser A, Mueller C. Use of Myeloperoxidase for Risk Stratification in Acute Heart Failure. Clin Chem. 2010 Jun;56(6):944-51. Epub 2010 Apr 22.
    • Rysler C, Stoffel N, Buser A, Gratwohl A, Tsakiris DA, Stern M. Effect of beta-blockers, Ca(2+) antagonists, and benzodiazepines on bleeding incidence in patients with chemotherapy induced thrombocytopenia. Platelets. 2010 Feb;21(1):77-83.
    • Medinger M, Skoda R, Gratwohl A, Theocharides A, Buser A, Heim D, Dirnhofer S, Tichelli A, Tzankov A. Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status. Br J Haematol. 2009 Jul;146(2):150-7. Epub 2009 May 19
    • Theocharides A, Passweg JR, Medinger M, Looser R, Li S, Hao-Shen H, Buser AS, Gratwohl A, Tichelli A, Skoda RC. The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders. Haematologica. 2008 Dec;93(12):1890-3. Epub 2008 Sep 11.
    • Liu K, Kralovics R, Rudzki Z, Grabowska B, Buser AS, Olcaydu D, Gisslinger H, Tiedt R, Frank P, Okon K, van der Maas AP, Skoda RC. A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family. Haematologica. 2008 May;93(5):706-14.
    • Stern M, Halter J, Buser A, Rovo A, Dirnhofer S, Häusermann P. Leukemia cutis preceding systemic relapse of acute myeloid leukaemia. Int J Hematol. 2008 Feb;87(2):108-9.
    • Martin Stern, Andreas S. Buser, Andreas Lohri, André Tichelli, and Catherine Nissen-Druey. Autoimmunity and malignancy in hematology - more than an association. Crit Rev Oncol Hematol. 2007 Aug;63(2):100-10. Epub 2007 Mar 27. Review.
    • Kralovics R, Teo SS, Li S, Theocharides A, Buser AS, Tichelli A, Skoda RC. Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood, 15 August 2006, Vol. 108, No. 4, pp. 1377-1380.
    • Arber C, Buser A, Heim D, Gratwohl A, Tichelli A, Passweg JR. Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome. Eur J Haematol. 2006 Mar;76 (3):255-7.
    • Kralovics R, Teo SS, Buser AS, Brutsche M, Tiedt R, Tichelli A, Passamonti F, Pietra D, Cazzola M, Skoda RC. Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2. Blood. 2005 Nov 15;106(10):3374-6.
    • Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005 Apr 28;352(17):1779-90.
       Kralovics R, Buser AS, Teo SS, Coers J, Tichelli A, van der Maas AP, Skoda RC. Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders. Blood. 2003 Sep 1;102(5):1869-71.

    Pubblicazioni del Servizio regionale trasfusionale Vaud

    • Busnel JM, Josserand J, Lion N, Girault HH : Ion­tophoretic Fraction Collection for Coupling Capillary Zone Electrophoresis with Matrix-As­sisted Laser Desorption/Ionization Mass Spec­trometry. Analytical Chemistry 2009, 81 : 3867-3872
    • Védy D, Robert D, Gasparini D, Canellini G, Waldvogel S, Tissot JD. Bacterial contamination of platelet concentrates : Pathogen detection and inactivation methods. A review of the literature. Hematol Rev 2009, 1 : e5
    • Rosselet A, Vu DH, Meylan P, Baur Chaubert A, Schapira M, Aubert V, Tissot JD, Duchosal MA. Association of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease. Clin Transplant, 2009, 23: 74-82
    • Pedrazzini B, Waldvogel S, Vaucher P, Bize R, Cornuz J, Tissot JD, Pecoud A, Favrat B. The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: a study protocol. Trials 2009, 10 :4
    • Cazenave JP, Folléa G, Bardiaux L, Boiron JM, Lafeuillade B, Debost M, Lioure B, Harousseau JL, Tabrizi R, Cahn JY, Michallet M, Ambruso D, Schots R, Tissot JD, Sensebé L, Kondo T, McCullough J, Rebulla P, Escolar G, Mintz P, Heddle NM, Goodrich RP, Bruhwyler J, Le C, Cook RJ, Stouch B (members of the The Mirasol Clinical Evaluation Study Group). A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion 2010, 50:2362-2375
    • Lion N, Crettaz D, Rubin O, Tissot JD. Stored red blood cells: a changing universe waiting for its map(s). J Proteomics, 2010, 73: 374-385
    • Tissot JD. Blood proteomics. J Proteomics, 2010, 73: 466-467
    • Canellini G, Waldvogel S, Anderegg K, Tissot JD. Bacterial contamination of platelet concentrates: Perspectives for the future. Laboratory Medicine, 2010, 41: 301-305
    • Rubin O, Crettaz D, Tissot JD, Lion N. Pre-analytical and methodological challenges in red blood cell microparticle proteomics. Talanta, 2010, 82: 1-8
    • Rubin O, Crettaz D, Tissot JD, Lion N. Microparticles in stored red blood cells: submicron clotting bombs ? Blood Transfus, 2010, Suppl 3: 31-38
    • Tissot JD, Rubin O, Canellini G. Analysis and clinical relevance of microparticles from red blood cells. Cur Opinion Hematol 2010, 17: 571-577
    • Laurent J, Speiser DE, Appay V, Touvrey C, Vicari M, Papaioannou A, Canellini G, Rimoldi D, Rufer N, Romero P, Leyvraz S, Voelter V. Impact of 3 different short-term chemotherapy regimens on lymphocyte-depletion and reconstitution in melanoma patients. J Immunother. 2010;33:723-34.
    • Waldvogel S, Natterer J, Canellini G, Truttmann A, Tissot JD. Severe neonatal hyporegenerative anemia due to anti-Vw (anti-MNS9) alloantibody. J Perinat Med.2009;37:422-4.
    • Girault H, Liu B, Qiao L, Bi H, Prudent M, Lion N, Abonnenc M. Electrochemical reactions and ionization processes. Eur J Mass Spectrom 2010;16(3):341-9.
    • Deriaz S, Bridel Grosvernier L, Tissot JD. Profession médecin: choix et perspective selon le genre. Rev Méd Suisse 2010 ; 6:1438-1442
    • Delobel J, Rubin O, Prudent M, Crettaz D, Tissot JD, Lion N. Biomarker analysis of stored blood products: emphasis on pre-analytical issues. Int J Mol Sci,, sous presse
    • Stolz M, Tinguely C, Graziani M, Fontana S, Gowland P, Buser A, Michel M,Canellini G, Züger M, Schumacher P, Lelie N, Niederhauser C. Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region. Transfusion sous presse
    • Ruegg C, Tissot JD, Farmer P, Mariotti A. Omics meets hypothesis-driven research Partnership for innovative discoveries in vascular biology and angiogenesis. Thrombosis and Haemostasis. 2008;100:738-746
    • Abonnenc M, Dayon L, Peruche B, Lion N, Girault HH. Electrospray micromixer chip for on-line derivatization and kinetic studies. Analytical Chemistry. 2008;80:3372-3378
    • Busnel JM, Lion N, Girault HH. Electrokinetic supercharging for highly efficient peptide preconcentration in capillary zone electrophoresis. Electrophoresis. 2008;29:1565-1572
    • Prudent M, Rossier JS, Lion N, Girault HH. Microfabricated dual sprayer for on-line mass tagging of phosphopeptides. Analytical Chemistry. 2008;80:2531-2538
    • Siegenthaler M.A, Vu DH, Ebnöter M, Ketterer N, Luthi F, Schmid P, Bargetzi M, Gasparini D, Tissot JD. « Agglutination and floculation » of stem cells collected by apharesis due to cryofibrinogen. Bone Marrow Transplant. 2004;33:765-767 (IF : 2.643)

    Pubblicazioni del Servizio regionale trasfusionale Zürich

    • Beat Frey, Urs Nydegger. Fortschritte in der Hämatologie. Pipette, Nr. 1, 10-11, 2010
    • Beat M. Frey, Peter Schlenke. Safeguards in Blood Supply: A National and European Challenge (Editorial). Transfusion Medicine and Hemotherapy, Volume 37, Issue 3, June 2010
    • P. Lodemann, G. Schorer, B.M. Frey. Wrong molar hemoglobin reference values – a longstanding error that should be corrected. Ann. Haematol. 2009;July 17, Epub ahead of print